Edesa Capital Expenditure vs Earnings per Basic Share Analysis

EDSA Stock  USD 4.45  0.33  8.01%   
Trend analysis of Edesa Biotech balance sheet accounts such as Total Current Liabilities of 1.3 M or Total Stockholder Equity of 6.4 M provides information on Edesa Biotech's total assets, liabilities, and equity, which is the actual value of Edesa Biotech to its prevalent stockholders. By breaking down trends over time using Edesa Biotech balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Edesa Biotech. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.
For information on how to trade Edesa Stock refer to our How to Trade Edesa Stock guide.

About Edesa Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Edesa Biotech at a specified time, usually calculated after every quarter, six months, or one year. Edesa Biotech Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Edesa Biotech and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Edesa currently owns. An asset can also be divided into two categories, current and non-current.

Edesa Biotech Balance Sheet Chart

Edesa Biotech Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Edesa Biotech uses and utilizes its capital. It also shows what exactly a company owns and owes.
At present, Edesa Biotech's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 209.5 K, whereas Total Assets are forecasted to decline to about 8.7 M.

Total Assets

Total assets refers to the total amount of Edesa Biotech assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Edesa Biotech books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Edesa Biotech balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Edesa Biotech are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Non Current Assets Total

The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.
Most indicators from Edesa Biotech's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Edesa Biotech current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Edesa Biotech. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.
For information on how to trade Edesa Stock refer to our How to Trade Edesa Stock guide.The current year's Issuance Of Capital Stock is expected to grow to about 8.3 M, whereas Selling General Administrative is forecasted to decline to about 3.6 M.
 2021 2022 2023 2024 (projected)
Cost Of Revenue118.2K183.5K165.1K156.9K
Research Development13.3M4.8M5.5M4.3M

Edesa Biotech fundamental ratios Correlations

0.370.350.75-0.8-0.590.810.410.230.890.20.410.130.260.970.210.320.24-0.370.190.730.44-0.140.60.450.14
0.370.99-0.2-0.41-0.280.440.260.220.290.250.160.460.80.33-0.290.13-0.280.080.62-0.1-0.25-0.20.020.05-0.17
0.350.99-0.21-0.4-0.240.430.250.230.270.260.170.440.790.31-0.330.13-0.320.070.6-0.09-0.3-0.21-0.020.09-0.11
0.75-0.2-0.21-0.34-0.570.360.440.280.580.250.470.02-0.440.690.320.390.35-0.58-0.480.860.56-0.240.750.660.19
-0.8-0.41-0.4-0.340.28-0.99-0.14-0.08-0.82-0.04-0.28-0.02-0.59-0.830.0-0.140.00.1-0.59-0.45-0.17-0.02-0.19-0.04-0.16
-0.59-0.28-0.24-0.570.28-0.32-0.49-0.24-0.53-0.43-0.16-0.630.02-0.53-0.36-0.02-0.410.560.17-0.54-0.570.32-0.93-0.380.49
0.810.440.430.36-0.99-0.320.210.150.810.120.290.090.590.83-0.040.15-0.04-0.150.570.470.15-0.040.230.080.15
0.410.260.250.44-0.14-0.490.210.920.050.880.570.59-0.090.21-0.360.47-0.33-0.75-0.270.39-0.15-0.810.450.640.17
0.230.220.230.28-0.08-0.240.150.92-0.140.950.610.52-0.090.04-0.660.53-0.63-0.71-0.270.29-0.45-0.890.20.630.32
0.890.290.270.58-0.82-0.530.810.05-0.14-0.120.11-0.010.370.960.45-0.050.45-0.10.360.620.640.250.510.16-0.05
0.20.250.260.25-0.04-0.430.120.880.95-0.120.50.72-0.10.02-0.590.42-0.56-0.72-0.30.27-0.36-0.910.350.580.06
0.410.160.170.47-0.28-0.160.290.570.610.110.50.15-0.130.28-0.40.5-0.38-0.62-0.250.41-0.23-0.60.160.590.34
0.130.460.440.02-0.02-0.630.090.590.52-0.010.720.150.140.03-0.250.09-0.22-0.37-0.06-0.05-0.13-0.610.440.15-0.51
0.260.80.79-0.44-0.590.020.59-0.09-0.090.37-0.1-0.130.140.31-0.18-0.13-0.190.350.96-0.27-0.210.17-0.28-0.35-0.08
0.970.330.310.69-0.83-0.530.830.210.040.960.020.280.030.310.310.220.33-0.210.270.670.530.050.530.310.09
0.21-0.29-0.330.320.0-0.36-0.04-0.36-0.660.45-0.59-0.4-0.25-0.180.31-0.421.00.1-0.070.240.910.610.46-0.13-0.33
0.320.130.130.39-0.14-0.020.150.470.53-0.050.420.50.09-0.130.22-0.42-0.4-0.28-0.220.13-0.32-0.660.090.360.42
0.24-0.28-0.320.350.0-0.41-0.04-0.33-0.630.45-0.56-0.38-0.22-0.190.331.0-0.40.06-0.090.260.920.580.5-0.11-0.34
-0.370.080.07-0.580.10.56-0.15-0.75-0.71-0.1-0.72-0.62-0.370.35-0.210.1-0.280.060.47-0.61-0.070.72-0.57-0.76-0.2
0.190.620.6-0.48-0.590.170.57-0.27-0.270.36-0.3-0.25-0.060.960.27-0.07-0.22-0.090.47-0.32-0.150.35-0.37-0.5-0.04
0.73-0.1-0.090.86-0.45-0.540.470.390.290.620.270.41-0.05-0.270.670.240.130.26-0.61-0.320.49-0.150.660.710.29
0.44-0.25-0.30.56-0.17-0.570.15-0.15-0.450.64-0.36-0.23-0.13-0.210.530.91-0.320.92-0.07-0.150.490.460.670.02-0.35
-0.14-0.2-0.21-0.24-0.020.32-0.04-0.81-0.890.25-0.91-0.6-0.610.170.050.61-0.660.580.720.35-0.150.46-0.25-0.55-0.17
0.60.02-0.020.75-0.19-0.930.230.450.20.510.350.160.44-0.280.530.460.090.5-0.57-0.370.660.67-0.250.46-0.4
0.450.050.090.66-0.04-0.380.080.640.630.160.580.590.15-0.350.31-0.130.36-0.11-0.76-0.50.710.02-0.550.460.42
0.14-0.17-0.110.19-0.160.490.150.170.32-0.050.060.34-0.51-0.080.09-0.330.42-0.34-0.2-0.040.29-0.35-0.17-0.40.42
Click cells to compare fundamentals

Edesa Biotech Account Relationship Matchups

Edesa Biotech fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets10.8M14.6M11.6M8.9M10.2M8.7M
Other Current Liab1.5M1.4M2.1M1.7M2.0M1.2M
Total Current Liabilities1.5M1.5M2.1M1.8M2.1M1.3M
Total Stockholder Equity6.6M13.1M9.4M7.0M8.1M6.4M
Net Debt(7.0M)(7.7M)(7.1M)(5.3M)(4.7M)(5.0M)
Retained Earnings(13.1M)(26.5M)(44.0M)(52.4M)(47.2M)(44.8M)
Cash7.2M7.8M7.1M5.4M6.2M5.6M
Non Current Assets Total2.7M2.5M2.5M2.5M2.8M3.0M
Cash And Short Term Investments7.2M7.8M7.1M5.4M6.2M6.8M
Common Stock Shares Outstanding8.6M12.1M16.7M20.0M23.0M24.2M
Liabilities And Stockholders Equity10.8M14.6M11.6M8.9M10.2M8.7M
Other Current Assets890.3K948.6K2.0M448.9K516.2K429.9K
Other Stockholder Equity1.3M4.7M11.2M13.0M15.0M15.7M
Total Liab4.1M1.5M2.2M1.8M2.1M2.3M
Total Current Assets8.1M12.1M9.1M6.4M7.4M7.6M
Property Plant And Equipment Net174.8K111.6K31.2K100.1K90.1K85.6K
Net Receivables87.4K3.3M1.3M626.5K720.5K521.2K
Property Plant And Equipment Gross174.8K145.4K70.7K143.9K129.5K123.1K
Accumulated Other Comprehensive Income(287.2K)(205.3K)(213.6K)(214.6K)(193.2K)(202.8K)
Non Current Liabilities Total2.6M67.7K43.7K19.8K17.8K16.9K
Inventory224.3K(217.1K)(87.4K)(1.3M)(1.1M)(1.1M)
Common Stock18.5M34.9M42.5M46.6M53.6M39.4M
Property Plant Equipment73.1K174.8K111.6K31.2K28.0K26.6K
Net Tangible Assets5.3M4.1M10.7M7.1M8.2M4.3M
Accounts Payable424.6K1.5M1.4M2.1M2.4M2.6M
Net Invested Capital6.6M13.1M9.4M7.0M8.1M9.4M
Net Working Capital6.6M10.6M7.0M4.6M4.2M5.8M
Capital Stock18.5M34.9M42.5M46.6M53.6M38.7M
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Edesa Biotech in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Edesa Biotech's short interest history, or implied volatility extrapolated from Edesa Biotech options trading.

Pair Trading with Edesa Biotech

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Edesa Biotech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Edesa Biotech will appreciate offsetting losses from the drop in the long position's value.

Moving against Edesa Stock

  0.65YS YS Biopharma Report 22nd of April 2024 PairCorr
  0.41MDGL Madrigal Pharmaceuticals Financial Report 14th of May 2024 PairCorr
  0.41MDWD Mediwound Financial Report 4th of June 2024 PairCorr
The ability to find closely correlated positions to Edesa Biotech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Edesa Biotech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Edesa Biotech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Edesa Biotech to buy it.
The correlation of Edesa Biotech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Edesa Biotech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Edesa Biotech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Edesa Biotech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Edesa Biotech offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Edesa Biotech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Edesa Biotech Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Edesa Biotech Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Edesa Biotech. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.
For information on how to trade Edesa Stock refer to our How to Trade Edesa Stock guide.
You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Complementary Tools for Edesa Stock analysis

When running Edesa Biotech's price analysis, check to measure Edesa Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edesa Biotech is operating at the current time. Most of Edesa Biotech's value examination focuses on studying past and present price action to predict the probability of Edesa Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edesa Biotech's price. Additionally, you may evaluate how the addition of Edesa Biotech to your portfolios can decrease your overall portfolio volatility.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Fundamental Analysis
View fundamental data based on most recent published financial statements
Commodity Directory
Find actively traded commodities issued by global exchanges
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Is Edesa Biotech's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Edesa Biotech. If investors know Edesa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Edesa Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(20.16)
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.56)
Return On Equity
(0.96)
The market value of Edesa Biotech is measured differently than its book value, which is the value of Edesa that is recorded on the company's balance sheet. Investors also form their own opinion of Edesa Biotech's value that differs from its market value or its book value, called intrinsic value, which is Edesa Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Edesa Biotech's market value can be influenced by many factors that don't directly affect Edesa Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Edesa Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Edesa Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Edesa Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.